<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="Janssen | REMICADE for IBD - Adult">
<title>Janssen | REMICADE for IBD - Adult</title>
<link rel="stylesheet" type="text/css" href="css/animate.min.css" />
<link rel="stylesheet" type="text/css" href="css/style.css" />
<style type="text/css">
	.content .feature { width: 620px; margin-left:0;  height:315px; background-image:url('img/graph_13.png'); }
	.content .orange { margin-bottom:15px; }
	.content .quote { height:258px; line-height:26px;  }
	
	/* bottom menu */ 
	.footer-menu li > ul { left:-12em; }
	.footer-menu .disease > ul { width:256px; left:-8em; }
	.footer-menu .mucosal > ul { width:342px; }
	.footer-menu .response > ul, .footer-menu .hosp > ul, .footer-menu .steroids > ul { width:170px; }
	.footer-menu .mucosal > ul {left: -11.7em; }
	.footer-menu .hosp > ul { left: -4.8em; }
	.footer-menu .steroids > ul { left: -4.6em; }
	.footer-menu .response > ul { left: -3.8em; }
	
</style> 
</head>
<body>
	<section class="content-wrapper sides">
    	<header>
        	<span class="remicade-logo right"></span> 
            <span class="section-label">Crohn’s<br />disease</span>
        	<div class="btn-menu">
                <ul class="popup-menu">
                    <li class="btn-home"><i></i></li>
                    <li class="btn-ref circle"></li>
                    <li class="btn-mpi circle"></li>
                    <li class="btn-info circle"></li>
                </ul>
            </div>
        </header>
    	<article class="inner-wrapper">
        	<div class="content">
                <h2 class="g-line">Adherence to REMICADE in Crohn’s disease patients<br />
with durable response was favoured over switching to<br />
adalimumab (Humira<sup>®†</sup>)<sup>1</sup></h2>
               
				<p class="orange">Treatment Cessation<sup>1</sup></p>
                <div class="feature"></div>
                <div class="footnote">
                	<span class="g-line">† Humira is a registered trademark of Abbvie New Zealand.</span>
                    <ul class="list">
                    	<li>Fewer REMICADE-treated patients stopped therapy due to loss of response<br />
                       	or intolerance vs. patients who switched to Humira<sup>®†</sup> (2% vs. 28%, p&lt;0.01)<sup>1</sup></li>
                        <li>Almost a third of patients who switched to Humira<sup>®†</sup> returned to REMICADE<br />
therapy within a year<sup>1</sup></li>
</ul>
                </div>
				 <div class="quote">
                	“Elective
switching to
[Humira<sup>®</sup>]
leads to worse
outcomes than
maintaining
treatment with
[REMICADE].”<sup>1</sup>
                
                </div> 
            </div>
       		<!--footer menu -->
            <ul class="footer-menu">
            	<li class="disease">
                	<ul>
                   		<li class="dc">Disease course</li>
                        <li class="pi">Patient indicators</li>
                       	<li class="tp">Treatment pathway</li>
                	</ul>
                    <span>Disease <br />Course</span>
                </li>
                <li class="response">
                	 <ul>
                       <li class="rr">Response <br />&amp;&nbsp;Remission</li>
                        <li class="sf">Steroid-free remission</li>
                	</ul>
                    <span>Response <br />&amp;&nbsp;Remission</span>
                </li>
                <li class="mucosal">
                	<ul>
                    	<li class="mh">Mucosal <br />Healing</li>
                        <li class="sb">Sustained benefit</li>
                        <li class="be">Body of evidence</li>
                        <li class="sy">Surgery</li>
                	</ul>
                <span>Mucosal <br />Healing</span>
                </li>
                <li class="hosp">
                	<ul>
                        <li class="hs">Hosp/Surg</li>
                        <li class="rs">Reductions</li>
                	</ul>
                    <span>Hosp/ <br />Surg</span>
                </li>
                <li class="steroids mid">
                    <ul>
                    	<li class="st">Steroids</li>
                        <li class="as">ACCENT & SONIC</li>
                	</ul>
                    <span>Steroids</span>
                </li>
                <li class="switch mid active">Switch</li>
            </ul>
       
        </article>
        <div class="popup ref">
            <h3>Reference</h3>
            <ol>
                <li class="ref1">Van Assche <em>et al</em>. Gut 2012; 61(2):229-234.</li>
            </ol>
        </div>
         <!--   Study design  -->
    	<div class="popup study-design">
    		<h3>Study design</h3>
         	SWITCH: An open-label randomised single-centre trial of 73 patients with ongoing response to ≥ 6
months of scheduled maintenance REMICADE. Patients were randomised to continue REMICADE or
to switch to adalimumab for 1 year. Dose optimisation was allowed for intermittent flares, and patients
with loss of response or intolerance could cross over to the alternative treatment group. Tolerability,
patient preference and efficacy lof both treatment options were the primary outcomes. Adapted from
van Assche <em>et al</em>.<sup>1</sup>
    	</div>
                
        <!-- popup main menu-->
        <aside class="main-menu animated">
        <span class="close circle"></span>
        	<ul class="level1">
            	<li class="cd">
                	<ul class="play">
                		<li class="home" data-slide="home">
                        	<span></span>
                        	<span></span>
                        	<span></span>
                        </li>
                		<li data-slide="cd">Crohn’s<br />disease</li>
                		<li data-slide="fist">Fistulising<br />Crohn’s disease</li>
                	</ul>
                </li>
                <li class="uc">
                	<ul class="play">
                    	<li data-slide="uc">Ulcerative<br />Colitis</li>
                		<li data-slide="ms">Moderate<br />Severe</li>
                		<li data-slide="as">Acute<br />Severe</li>
                	</ul>
                </li>
                <li class="common">
                	<ul class="play">
                		<li data-slide="st">Safety<br />& Tolerability</li>
                		<li data-slide="do">Dosing</li>
                		<li data-slide="ad">Adherence</li>
                		<li data-slide="pr">Preference</li>
                	</ul>
                </li>
            </ul>
        </aside>
        
    </section>
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript">
	$( function(){
		
		$('.inner-wrapper').on('swiperight', function(){
			setStore();
		});
		$('.steroids .as').on('tap', function(){
			setStore();
		});
		function setStore(){ localStorage.setItem('fromSonic', '1'); }
		
		
		goToSlide('disease .dc', 'CD1601-Disease-course');
		goToSlide('disease .pi', 'CD1602-Patient-indicators');
		goToSlide('disease .tp', 'CD1603-Treatment-pathway');
		goToSlide('response .rr', 'CD1604-Response-and-remission');
		goToSlide('response .sf, .steroids .as', 'CD1605-Steroid-free-remission');
		goToSlide('mucosal .mh', 'CD1606-Mucosal-healing');
		goToSlide('mucosal .sb', 'CD1607-Sustained-benefit');
		goToSlide('mucosal .be', 'CD1608-Body-of-evidence');
		goToSlide('mucosal .sy', 'CD1609-Surgery');
		goToSlide('hosp .hs', 'CD1610-Hosp-surg');
		goToSlide('hosp .rs', 'CD1611-Reductions');
		goToSlide('steroids .st', 'CD1612-Steroids');
		//goToSlide('switch', 'CD1613-Switch');
		
		//reference
		goToSlide('ref1', 'VanA2012');
	})
	
	
</script>
</body>
</html>
